APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cognitive Decline

Compare research editions
View pricing & licenses

Selected research

Industry Research

Cognitive Decline Industry Research Report 2026

Report ID 173979330529 December 2025141 pages

Choose your research edition.

Industry ResearchCognitive Decline Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Cognitive Decline Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Cognitive Decline Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cognitive Decline Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Cognitive Decline Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Cognitive Decline market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Cognitive Decline market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Cognitive Decline market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Cognitive Decline market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Cognitive Decline include Stryker, TrueKAST (Wound Kair Concepts), Thuasne SAS, Talley Group Limited, Smith & Nephew, PROMA REHA, s. r. o., Paramount Bed Holdings Co., Ltd., ORTHOSERVICE AG and Mölnlycke Health Care, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Cognitive Decline market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cognitive Decline.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Cognitive Decline Market by Company

Stryker

TrueKAST (Wound Kair Concepts)

Thuasne SAS

Talley Group Limited

Smith & Nephew

PROMA REHA, s. r. o.

Paramount Bed Holdings Co., Ltd.

ORTHOSERVICE AG

Mölnlycke Health Care

Medtronic

Medline Industries Inc.

Linet spol. S R.O.

Invacare Corporation

Hollister Incorporated

Hill-Rom Services Inc.

Drive DeVilbiss Healthcare Ltd (Sidhil Limited)

DJO Global

DeRoyal Industries

DARCO International

ConvaTec Group plc

Coloplast A/S

BSN Medical (Essity)

Breg, Inc.

ArjoHuntleigh

Apex Medical Corp.

ALGEOS

Advanced Orthopaedics

Cognitive Decline Segment by Type

by Drug Therapy

by Non-Invasive Stimulation Devices

Cognitive Decline Segment by Application

Mild Cognitive Impairment (MCI)

Dementia

Cognitive Decline Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cognitive Decline market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cognitive Decline and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cognitive Decline.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Cognitive Decline companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Cognitive Decline Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Cognitive Decline Revenue Market Share by Type (2021-2026) Table 7. Global Cognitive Decline Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Cognitive Decline Revenue Market Share by Type (2027-2032) Table 9. Global Cognitive Decline Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Cognitive Decline Revenue Market Share by Application (2021-2026) Table 11. Global Cognitive Decline Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Cognitive Decline Revenue Market Share by Application (2027-2032) Table 13. Global Cognitive Decline Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Cognitive Decline Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Cognitive Decline Market Share by Region (2021-2026) Table 16. Global Cognitive Decline Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Cognitive Decline Market Share by Region (2027-2032) Table 18. Cognitive Decline Industry Trends Table 19. Cognitive Decline Industry Drivers Table 20. Cognitive Decline Industry Opportunities and Challenges Table 21. Cognitive Decline Market Restraints Table 22. Global Top Cognitive Decline Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Cognitive Decline Revenue Market Share by Players (2021-2026) Table 24. Global Cognitive Decline Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Cognitive Decline, Headquarters and Area Served Table 26. Global Cognitive Decline Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Cognitive Decline by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Cognitive Decline Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Cognitive Decline Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Cognitive Decline Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Cognitive Decline Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Cognitive Decline Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Cognitive Decline Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Cognitive Decline Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Cognitive Decline Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Cognitive Decline Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Cognitive Decline Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Cognitive Decline Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Cognitive Decline Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Cognitive Decline Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Cognitive Decline Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Cognitive Decline Market Size by Country (2027-2032) & (US$ Million) Table 45. Stryker Company Information Table 46. Stryker Business Overview Table 47. Stryker Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 48. Stryker Cognitive Decline Product Portfolio Table 49. Stryker Recent Developments Table 50. TrueKAST (Wound Kair Concepts) Company Information Table 51. TrueKAST (Wound Kair Concepts) Business Overview Table 52. TrueKAST (Wound Kair Concepts) Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 53. TrueKAST (Wound Kair Concepts) Cognitive Decline Product Portfolio Table 54. TrueKAST (Wound Kair Concepts) Recent Developments Table 55. Thuasne SAS Company Information Table 56. Thuasne SAS Business Overview Table 57. Thuasne SAS Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 58. Thuasne SAS Cognitive Decline Product Portfolio Table 59. Thuasne SAS Recent Developments Table 60. Talley Group Limited Company Information Table 61. Talley Group Limited Business Overview Table 62. Talley Group Limited Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 63. Talley Group Limited Cognitive Decline Product Portfolio Table 64. Talley Group Limited Recent Developments Table 65. Smith & Nephew Company Information Table 66. Smith & Nephew Business Overview Table 67. Smith & Nephew Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 68. Smith & Nephew Cognitive Decline Product Portfolio Table 69. Smith & Nephew Recent Developments Table 70. PROMA REHA, s. r. o. Company Information Table 71. PROMA REHA, s. r. o. Business Overview Table 72. PROMA REHA, s. r. o. Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 73. PROMA REHA, s. r. o. Cognitive Decline Product Portfolio Table 74. PROMA REHA, s. r. o. Recent Developments Table 75. Paramount Bed Holdings Co., Ltd. Company Information Table 76. Paramount Bed Holdings Co., Ltd. Business Overview Table 77. Paramount Bed Holdings Co., Ltd. Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 78. Paramount Bed Holdings Co., Ltd. Cognitive Decline Product Portfolio Table 79. Paramount Bed Holdings Co., Ltd. Recent Developments Table 80. ORTHOSERVICE AG Company Information Table 81. ORTHOSERVICE AG Business Overview Table 82. ORTHOSERVICE AG Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 83. ORTHOSERVICE AG Cognitive Decline Product Portfolio Table 84. ORTHOSERVICE AG Recent Developments Table 85. Mölnlycke Health Care Company Information Table 86. Mölnlycke Health Care Business Overview Table 87. Mölnlycke Health Care Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 88. Mölnlycke Health Care Cognitive Decline Product Portfolio Table 89. Mölnlycke Health Care Recent Developments Table 90. Medtronic Company Information Table 91. Medtronic Business Overview Table 92. Medtronic Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 93. Medtronic Cognitive Decline Product Portfolio Table 94. Medtronic Recent Developments Table 95. Medline Industries Inc. Company Information Table 96. Medline Industries Inc. Business Overview Table 97. Medline Industries Inc. Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 98. Medline Industries Inc. Cognitive Decline Product Portfolio Table 99. Medline Industries Inc. Recent Developments Table 100. Linet spol. S R.O. Company Information Table 101. Linet spol. S R.O. Business Overview Table 102. Linet spol. S R.O. Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 103. Linet spol. S R.O. Cognitive Decline Product Portfolio Table 104. Linet spol. S R.O. Recent Developments Table 105. Invacare Corporation Company Information Table 106. Invacare Corporation Business Overview Table 107. Invacare Corporation Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 108. Invacare Corporation Cognitive Decline Product Portfolio Table 109. Invacare Corporation Recent Developments Table 110. Hollister Incorporated Company Information Table 111. Hollister Incorporated Business Overview Table 112. Hollister Incorporated Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 113. Hollister Incorporated Cognitive Decline Product Portfolio Table 114. Hollister Incorporated Recent Developments Table 115. Hill-Rom Services Inc. Company Information Table 116. Hill-Rom Services Inc. Business Overview Table 117. Hill-Rom Services Inc. Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 118. Hill-Rom Services Inc. Cognitive Decline Product Portfolio Table 119. Hill-Rom Services Inc. Recent Developments Table 120. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Company Information Table 121. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Business Overview Table 122. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 123. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Cognitive Decline Product Portfolio Table 124. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Recent Developments Table 125. DJO Global Company Information Table 126. DJO Global Business Overview Table 127. DJO Global Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 128. DJO Global Cognitive Decline Product Portfolio Table 129. DJO Global Recent Developments Table 130. DeRoyal Industries Company Information Table 131. DeRoyal Industries Business Overview Table 132. DeRoyal Industries Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 133. DeRoyal Industries Cognitive Decline Product Portfolio Table 134. DeRoyal Industries Recent Developments Table 135. DARCO International Company Information Table 136. DARCO International Business Overview Table 137. DARCO International Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 138. DARCO International Cognitive Decline Product Portfolio Table 139. DARCO International Recent Developments Table 140. ConvaTec Group plc Company Information Table 141. ConvaTec Group plc Business Overview Table 142. ConvaTec Group plc Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 143. ConvaTec Group plc Cognitive Decline Product Portfolio Table 144. ConvaTec Group plc Recent Developments Table 145. Coloplast A/S Company Information Table 146. Coloplast A/S Business Overview Table 147. Coloplast A/S Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 148. Coloplast A/S Cognitive Decline Product Portfolio Table 149. Coloplast A/S Recent Developments Table 150. BSN Medical (Essity) Company Information Table 151. BSN Medical (Essity) Business Overview Table 152. BSN Medical (Essity) Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 153. BSN Medical (Essity) Cognitive Decline Product Portfolio Table 154. BSN Medical (Essity) Recent Developments Table 155. Breg, Inc. Company Information Table 156. Breg, Inc. Business Overview Table 157. Breg, Inc. Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 158. Breg, Inc. Cognitive Decline Product Portfolio Table 159. Breg, Inc. Recent Developments Table 160. ArjoHuntleigh Company Information Table 161. ArjoHuntleigh Business Overview Table 162. ArjoHuntleigh Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 163. ArjoHuntleigh Cognitive Decline Product Portfolio Table 164. ArjoHuntleigh Recent Developments Table 165. Apex Medical Corp. Company Information Table 166. Apex Medical Corp. Business Overview Table 167. Apex Medical Corp. Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 168. Apex Medical Corp. Cognitive Decline Product Portfolio Table 169. Apex Medical Corp. Recent Developments Table 170. ALGEOS Company Information Table 171. ALGEOS Business Overview Table 172. ALGEOS Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 173. ALGEOS Cognitive Decline Product Portfolio Table 174. ALGEOS Recent Developments Table 175. Advanced Orthopaedics Company Information Table 176. Advanced Orthopaedics Business Overview Table 177. Advanced Orthopaedics Revenue in Cognitive Decline Business (2021-2026) & (US$ Million) Table 178. Advanced Orthopaedics Cognitive Decline Product Portfolio Table 179. Advanced Orthopaedics Recent Developments Table 180. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Cognitive Decline Product Image Figure 5. Global Cognitive Decline Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Cognitive Decline Market Share by Type: 2025 VS 2032 Figure 7. Product Figure 8. Product Figure 9. Global Cognitive Decline Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Cognitive Decline Market Share by Application: 2025 VS 2032 Figure 11. Mild Cognitive Impairment (MCI) Product Figure 12. Dementia Product Figure 13. Global Cognitive Decline Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 14. Global Cognitive Decline Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Cognitive Decline Market Share by Region: 2025 VS 2032 Figure 16. Global Cognitive Decline Market Share by Players in 2025 Figure 17. Global Cognitive Decline Manufacturers Established Date Figure 18. Global Top 5 and 10 Cognitive Decline Players Market Share by Revenue in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. North America Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 21. North America Cognitive Decline Market Share by Country (2021-2032) Figure 22. United States Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 23. Canada Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Mexico Cognitive Decline Market Share by Country (2021-2032) Figure 25. Europe Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Europe Cognitive Decline Market Share by Country (2021-2032) Figure 27. Germany Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. France Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. U.K. Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. Italy Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Spain Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Russia Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Netherlands Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Nordic Countries Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Cognitive Decline Market Share by Country (2021-2032) Figure 37. China Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Japan Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. South Korea Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. India Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. India Cognitive Decline Market Share by Country (2021-2032) Figure 42. Australia Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. China Taiwan Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. Southeast Asia Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. South America Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. South America Cognitive Decline Market Share by Country (2021-2032) Figure 47. Brazil Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. Argentina Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. Chile Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Colombia Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Peru Cognitive Decline Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Stryker Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 53. TrueKAST (Wound Kair Concepts) Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 54. Thuasne SAS Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 55. Talley Group Limited Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 56. Smith & Nephew Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 57. PROMA REHA, s. r. o. Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 58. Paramount Bed Holdings Co., Ltd. Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 59. ORTHOSERVICE AG Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 60. Mölnlycke Health Care Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 61. Medtronic Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 62. Medline Industries Inc. Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 63. Linet spol. S R.O. Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 64. Invacare Corporation Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 65. Hollister Incorporated Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 66. Hill-Rom Services Inc. Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 67. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 68. DJO Global Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 69. DeRoyal Industries Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 70. DARCO International Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 71. ConvaTec Group plc Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 72. Coloplast A/S Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 73. BSN Medical (Essity) Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 74. Breg, Inc. Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 75. ArjoHuntleigh Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 76. Apex Medical Corp. Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 77. ALGEOS Revenue Growth Rate in Cognitive Decline Business (2021-2026) Figure 78. Advanced Orthopaedics Revenue Growth Rate in Cognitive Decline Business (2021-2026)

Scope & coverage.

Applications
  • Mild Cognitive Impairment (MCI)
  • Dementia
Companies covered
  • Stryker
  • TrueKAST (Wound Kair Concepts)
  • Thuasne SAS
  • Talley Group Limited
  • Smith & Nephew
  • PROMA REHA, s. r. o.
  • Paramount Bed Holdings Co., Ltd.
  • ORTHOSERVICE AG
  • Mölnlycke Health Care
  • Medtronic
  • Medline Industries Inc.
  • Linet spol. S R.O.
  • Invacare Corporation
  • Hollister Incorporated
  • Hill-Rom Services Inc.
  • Drive DeVilbiss Healthcare Ltd (Sidhil Limited)
  • DJO Global
  • DeRoyal Industries
  • DARCO International
  • ConvaTec Group plc
  • Coloplast A/S
  • BSN Medical (Essity)
  • Breg, Inc.
  • ArjoHuntleigh
  • Apex Medical Corp.
  • ALGEOS
  • Advanced Orthopaedics

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Cognitive Decline by Drug Therapy
  3. 2.2.1 Market Value Comparison by Drug Therapy (2021 VS 2025 VS 2032)
  4. 2.2.2 by Drug Therapy
  5. 2.2.3 by Non-Invasive Stimulation Devices
  6. 2.3 Cognitive Decline by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  8. 2.3.2 Mild Cognitive Impairment (MCI)
  9. 2.3.3 Dementia
  10. 2.4 Assumptions and Limitations
3 Cognitive Decline Breakdown Data by Type
  1. 3.1 Global Cognitive Decline Historic Market Size by Type (2021-2026)
  2. 3.2 Global Cognitive Decline Forecasted Market Size by Type (2027-2032)
4 Cognitive Decline Breakdown Data by Application
  1. 4.1 Global Cognitive Decline Historic Market Size by Application (2021-2026)
  2. 4.2 Global Cognitive Decline Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Cognitive Decline Market Perspective (2021-2032)
  2. 5.2 Global Cognitive Decline Growth Trends by Region
  3. 5.2.1 Global Cognitive Decline Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Cognitive Decline Historic Market Size by Region (2021-2026)
  5. 5.2.3 Cognitive Decline Forecasted Market Size by Region (2027-2032)
  6. 5.3 Cognitive Decline Market Dynamics
  7. 5.3.1 Cognitive Decline Industry Trends
  8. 5.3.2 Cognitive Decline Market Drivers
  9. 5.3.3 Cognitive Decline Market Challenges
  10. 5.3.4 Cognitive Decline Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Cognitive Decline Players by Revenue
  2. 6.1.1 Global Top Cognitive Decline Players by Revenue (2021-2026)
  3. 6.1.2 Global Cognitive Decline Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Cognitive Decline Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Cognitive Decline Head Office and Area Served
  6. 6.4 Global Cognitive Decline Players, Product Type & Application
  7. 6.5 Global Cognitive Decline Manufacturers Established Date
  8. 6.6 Global Cognitive Decline Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Cognitive Decline Market Size (2021-2032)
  2. 7.2 North America Cognitive Decline Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Cognitive Decline Market Size by Country (2021-2026)
  4. 7.4 North America Cognitive Decline Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Cognitive Decline Market Size (2021-2032)
  2. 8.2 Europe Cognitive Decline Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Cognitive Decline Market Size by Country (2021-2026)
  4. 8.4 Europe Cognitive Decline Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Cognitive Decline Market Size (2021-2032)
  2. 9.2 Asia-Pacific Cognitive Decline Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Cognitive Decline Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Cognitive Decline Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Cognitive Decline Market Size (2021-2032)
  2. 10.2 South America Cognitive Decline Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Cognitive Decline Market Size by Country (2021-2026)
  4. 10.4 South America Cognitive Decline Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Cognitive Decline Market Size (2021-2032)
  2. 11.2 Middle East & Africa Cognitive Decline Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Cognitive Decline Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Cognitive Decline Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Stryker
  2. 12.1.1 Stryker Company Information
  3. 12.1.2 Stryker Business Overview
  4. 12.1.3 Stryker Revenue in Cognitive Decline Business (2021-2026)
  5. 12.1.4 Stryker Cognitive Decline Product Portfolio
  6. 12.1.5 Stryker Recent Developments
  7. 12.2 TrueKAST (Wound Kair Concepts)
  8. 12.2.1 TrueKAST (Wound Kair Concepts) Company Information
  9. 12.2.2 TrueKAST (Wound Kair Concepts) Business Overview
  10. 12.2.3 TrueKAST (Wound Kair Concepts) Revenue in Cognitive Decline Business (2021-2026)
  11. 12.2.4 TrueKAST (Wound Kair Concepts) Cognitive Decline Product Portfolio
  12. 12.2.5 TrueKAST (Wound Kair Concepts) Recent Developments
  13. 12.3 Thuasne SAS
  14. 12.3.1 Thuasne SAS Company Information
  15. 12.3.2 Thuasne SAS Business Overview
  16. 12.3.3 Thuasne SAS Revenue in Cognitive Decline Business (2021-2026)
  17. 12.3.4 Thuasne SAS Cognitive Decline Product Portfolio
  18. 12.3.5 Thuasne SAS Recent Developments
  19. 12.4 Talley Group Limited
  20. 12.4.1 Talley Group Limited Company Information
  21. 12.4.2 Talley Group Limited Business Overview
  22. 12.4.3 Talley Group Limited Revenue in Cognitive Decline Business (2021-2026)
  23. 12.4.4 Talley Group Limited Cognitive Decline Product Portfolio
  24. 12.4.5 Talley Group Limited Recent Developments
  25. 12.5 Smith & Nephew
  26. 12.5.1 Smith & Nephew Company Information
  27. 12.5.2 Smith & Nephew Business Overview
  28. 12.5.3 Smith & Nephew Revenue in Cognitive Decline Business (2021-2026)
  29. 12.5.4 Smith & Nephew Cognitive Decline Product Portfolio
  30. 12.5.5 Smith & Nephew Recent Developments
  31. 12.6 PROMA REHA, s. r. o.
  32. 12.6.1 PROMA REHA, s. r. o. Company Information
  33. 12.6.2 PROMA REHA, s. r. o. Business Overview
  34. 12.6.3 PROMA REHA, s. r. o. Revenue in Cognitive Decline Business (2021-2026)
  35. 12.6.4 PROMA REHA, s. r. o. Cognitive Decline Product Portfolio
  36. 12.6.5 PROMA REHA, s. r. o. Recent Developments
  37. 12.7 Paramount Bed Holdings Co., Ltd.
  38. 12.7.1 Paramount Bed Holdings Co., Ltd. Company Information
  39. 12.7.2 Paramount Bed Holdings Co., Ltd. Business Overview
  40. 12.7.3 Paramount Bed Holdings Co., Ltd. Revenue in Cognitive Decline Business (2021-2026)
  41. 12.7.4 Paramount Bed Holdings Co., Ltd. Cognitive Decline Product Portfolio
  42. 12.7.5 Paramount Bed Holdings Co., Ltd. Recent Developments
  43. 12.8 ORTHOSERVICE AG
  44. 12.8.1 ORTHOSERVICE AG Company Information
  45. 12.8.2 ORTHOSERVICE AG Business Overview
  46. 12.8.3 ORTHOSERVICE AG Revenue in Cognitive Decline Business (2021-2026)
  47. 12.8.4 ORTHOSERVICE AG Cognitive Decline Product Portfolio
  48. 12.8.5 ORTHOSERVICE AG Recent Developments
  49. 12.9 Mölnlycke Health Care
  50. 12.9.1 Mölnlycke Health Care Company Information
  51. 12.9.2 Mölnlycke Health Care Business Overview
  52. 12.9.3 Mölnlycke Health Care Revenue in Cognitive Decline Business (2021-2026)
  53. 12.9.4 Mölnlycke Health Care Cognitive Decline Product Portfolio
  54. 12.9.5 Mölnlycke Health Care Recent Developments
  55. 12.10 Medtronic
  56. 12.10.1 Medtronic Company Information
  57. 12.10.2 Medtronic Business Overview
  58. 12.10.3 Medtronic Revenue in Cognitive Decline Business (2021-2026)
  59. 12.10.4 Medtronic Cognitive Decline Product Portfolio
  60. 12.10.5 Medtronic Recent Developments
  61. 12.11 Medline Industries Inc.
  62. 12.11.1 Medline Industries Inc. Company Information
  63. 12.11.2 Medline Industries Inc. Business Overview
  64. 12.11.3 Medline Industries Inc. Revenue in Cognitive Decline Business (2021-2026)
  65. 12.11.4 Medline Industries Inc. Cognitive Decline Product Portfolio
  66. 12.11.5 Medline Industries Inc. Recent Developments
  67. 12.12 Linet spol. S R.O.
  68. 12.12.1 Linet spol. S R.O. Company Information
  69. 12.12.2 Linet spol. S R.O. Business Overview
  70. 12.12.3 Linet spol. S R.O. Revenue in Cognitive Decline Business (2021-2026)
  71. 12.12.4 Linet spol. S R.O. Cognitive Decline Product Portfolio
  72. 12.12.5 Linet spol. S R.O. Recent Developments
  73. 12.13 Invacare Corporation
  74. 12.13.1 Invacare Corporation Company Information
  75. 12.13.2 Invacare Corporation Business Overview
  76. 12.13.3 Invacare Corporation Revenue in Cognitive Decline Business (2021-2026)
  77. 12.13.4 Invacare Corporation Cognitive Decline Product Portfolio
  78. 12.13.5 Invacare Corporation Recent Developments
  79. 12.14 Hollister Incorporated
  80. 12.14.1 Hollister Incorporated Company Information
  81. 12.14.2 Hollister Incorporated Business Overview
  82. 12.14.3 Hollister Incorporated Revenue in Cognitive Decline Business (2021-2026)
  83. 12.14.4 Hollister Incorporated Cognitive Decline Product Portfolio
  84. 12.14.5 Hollister Incorporated Recent Developments
  85. 12.15 Hill-Rom Services Inc.
  86. 12.15.1 Hill-Rom Services Inc. Company Information
  87. 12.15.2 Hill-Rom Services Inc. Business Overview
  88. 12.15.3 Hill-Rom Services Inc. Revenue in Cognitive Decline Business (2021-2026)
  89. 12.15.4 Hill-Rom Services Inc. Cognitive Decline Product Portfolio
  90. 12.15.5 Hill-Rom Services Inc. Recent Developments
  91. 12.16 Drive DeVilbiss Healthcare Ltd (Sidhil Limited)
  92. 12.16.1 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Company Information
  93. 12.16.2 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Business Overview
  94. 12.16.3 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Revenue in Cognitive Decline Business (2021-2026)
  95. 12.16.4 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Cognitive Decline Product Portfolio
  96. 12.16.5 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Recent Developments
  97. 12.17 DJO Global
  98. 12.17.1 DJO Global Company Information
  99. 12.17.2 DJO Global Business Overview
  100. 12.17.3 DJO Global Revenue in Cognitive Decline Business (2021-2026)
  101. 12.17.4 DJO Global Cognitive Decline Product Portfolio
  102. 12.17.5 DJO Global Recent Developments
  103. 12.18 DeRoyal Industries
  104. 12.18.1 DeRoyal Industries Company Information
  105. 12.18.2 DeRoyal Industries Business Overview
  106. 12.18.3 DeRoyal Industries Revenue in Cognitive Decline Business (2021-2026)
  107. 12.18.4 DeRoyal Industries Cognitive Decline Product Portfolio
  108. 12.18.5 DeRoyal Industries Recent Developments
  109. 12.19 DARCO International
  110. 12.19.1 DARCO International Company Information
  111. 12.19.2 DARCO International Business Overview
  112. 12.19.3 DARCO International Revenue in Cognitive Decline Business (2021-2026)
  113. 12.19.4 DARCO International Cognitive Decline Product Portfolio
  114. 12.19.5 DARCO International Recent Developments
  115. 12.20 ConvaTec Group plc
  116. 12.20.1 ConvaTec Group plc Company Information
  117. 12.20.2 ConvaTec Group plc Business Overview
  118. 12.20.3 ConvaTec Group plc Revenue in Cognitive Decline Business (2021-2026)
  119. 12.20.4 ConvaTec Group plc Cognitive Decline Product Portfolio
  120. 12.20.5 ConvaTec Group plc Recent Developments
  121. 12.21 Coloplast A/S
  122. 12.21.1 Coloplast A/S Company Information
  123. 12.21.2 Coloplast A/S Business Overview
  124. 12.21.3 Coloplast A/S Revenue in Cognitive Decline Business (2021-2026)
  125. 12.21.4 Coloplast A/S Cognitive Decline Product Portfolio
  126. 12.21.5 Coloplast A/S Recent Developments
  127. 12.22 BSN Medical (Essity)
  128. 12.22.1 BSN Medical (Essity) Company Information
  129. 12.22.2 BSN Medical (Essity) Business Overview
  130. 12.22.3 BSN Medical (Essity) Revenue in Cognitive Decline Business (2021-2026)
  131. 12.22.4 BSN Medical (Essity) Cognitive Decline Product Portfolio
  132. 12.22.5 BSN Medical (Essity) Recent Developments
  133. 12.23 Breg, Inc.
  134. 12.23.1 Breg, Inc. Company Information
  135. 12.23.2 Breg, Inc. Business Overview
  136. 12.23.3 Breg, Inc. Revenue in Cognitive Decline Business (2021-2026)
  137. 12.23.4 Breg, Inc. Cognitive Decline Product Portfolio
  138. 12.23.5 Breg, Inc. Recent Developments
  139. 12.24 ArjoHuntleigh
  140. 12.24.1 ArjoHuntleigh Company Information
  141. 12.24.2 ArjoHuntleigh Business Overview
  142. 12.24.3 ArjoHuntleigh Revenue in Cognitive Decline Business (2021-2026)
  143. 12.24.4 ArjoHuntleigh Cognitive Decline Product Portfolio
  144. 12.24.5 ArjoHuntleigh Recent Developments
  145. 12.25 Apex Medical Corp.
  146. 12.25.1 Apex Medical Corp. Company Information
  147. 12.25.2 Apex Medical Corp. Business Overview
  148. 12.25.3 Apex Medical Corp. Revenue in Cognitive Decline Business (2021-2026)
  149. 12.25.4 Apex Medical Corp. Cognitive Decline Product Portfolio
  150. 12.25.5 Apex Medical Corp. Recent Developments
  151. 12.26 ALGEOS
  152. 12.26.1 ALGEOS Company Information
  153. 12.26.2 ALGEOS Business Overview
  154. 12.26.3 ALGEOS Revenue in Cognitive Decline Business (2021-2026)
  155. 12.26.4 ALGEOS Cognitive Decline Product Portfolio
  156. 12.26.5 ALGEOS Recent Developments
  157. 12.27 Advanced Orthopaedics
  158. 12.27.1 Advanced Orthopaedics Company Information
  159. 12.27.2 Advanced Orthopaedics Business Overview
  160. 12.27.3 Advanced Orthopaedics Revenue in Cognitive Decline Business (2021-2026)
  161. 12.27.4 Advanced Orthopaedics Cognitive Decline Product Portfolio
  162. 12.27.5 Advanced Orthopaedics Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst